Literature DB >> 1793831

Total and HDL cholesterol in human hematologic neoplasms.

S Dessì1, B Batetta, D Pulisci, P Accogli, P Pani, G Broccia.   

Abstract

In this study serum cholesterol was measured in different types of human hematologic malignancies characterized by a wide range of cell proliferation. In all tumoral types a significant decrease of HDL cholesterol was observed, whereas total serum cholesterol generally remained unchanged. Another interesting observation of our study was the apparent inverse correlation between the extent of cell proliferation in these neoplastic disorders and the level of HDL cholesterol. Since a decrease of HDL cholesterol was previously observed, in our laboratory, in different experimental models of normal and neoplastic cell proliferation, we suggest that the decrease of HDL cholesterol may be a generalized phenomenon related to massive cellular growth in normal and malignant processes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793831

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  10 in total

1.  Role of cholesterol synthesis and esterification in the growth of CEM and MOLT4 lymphoblastic cells.

Authors:  S Dessi; B Batetta; A Pani; O Spano; F Sanna; M Putzolu; R Bonatesta; S Piras; P Pani
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  Cell cholesterol esters and high-density lipoprotein plasma levels during liver hyperplasia in choline-fed male and female rats.

Authors:  L Tessitore; B Batetta; B Vizio; M F Mulas; B Marengo; S Dessi
Journal:  Int J Exp Pathol       Date:  2000-08       Impact factor: 1.925

3.  Correlation between cholesterol esterification, MDR1 gene expression and rate of cell proliferation in CEM and MOLT4 cell lines.

Authors:  B Batetta; A Pani; M Putzolu; F Sanna; R Bonatesta; S Piras; O Spano; M F Mulas; S Dessí
Journal:  Cell Prolif       Date:  1999-02       Impact factor: 6.831

4.  Lipid profile in leukemia and Hodgkin's disease.

Authors:  P P Naik; M S Ghadge; A S Raste
Journal:  Indian J Clin Biochem       Date:  2006-09

5.  Cholesterol esterification during differentiation of mouse erythroleukemia (Friend) cells.

Authors:  Maria Franca Mulas; Antonella Mandas; Claudia Abete; Sandra Dessì; Alessandra Mocali; Francesco Paoletti
Journal:  Hematol Rep       Date:  2011-10-19

Review 6.  Lipoprotein Drug Delivery Vehicles for Cancer: Rationale and Reason.

Authors:  Jaideep Chaudhary; Joseph Bower; Ian R Corbin
Journal:  Int J Mol Sci       Date:  2019-12-15       Impact factor: 5.923

7.  The Effect of Dietary Intervention With High-Oleocanthal and Oleacein Olive Oil in Patients With Early-Stage Chronic Lymphocytic Leukemia: A Pilot Randomized Trial.

Authors:  Andrea Paola Rojas Gil; Ioannis Kodonis; Anastasios Ioannidis; Tzortzis Nomikos; Ioannis Dimopoulos; Georgios Kosmidis; Maria Efthymia Katsa; Eleni Melliou; Prokopios Magiatis
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

8.  Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130).

Authors:  S Dessí; B Batetta; C Anchisi; P Pani; P Costelli; L Tessitore; F M Baccino
Journal:  Br J Cancer       Date:  1992-11       Impact factor: 7.640

9.  Perturbations of triglycerides but not of cholesterol metabolism are prevented by anti-tumour necrosis factor treatment in rats bearing an ascites hepatoma (Yoshida AH-130).

Authors:  S Dessì; B Batetta; O Spano; G J Bagby; L Tessitore; P Costelli; F M Baccino; P Pani; J M Argilès
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

10.  Lipid changes occuring in the course of hematological cancers.

Authors:  Małgorzata Kuliszkiewicz-Janus; Rafał Małecki; Abdulrahman Saeed Mohamed
Journal:  Cell Mol Biol Lett       Date:  2008-05-06       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.